Although MED1 overexpression itself does not induce mammary tumor formation, we observed significantly promoted tumor onset, growth, metastasis, and elevated primary tumor multiplicity in MMTV-HER2/MMTV-MED1 double-transgenic mice. This evidence concerns the gene ERBB2 and breast cancer.